Selonterra
1025 Alameda De Las Pulgas
Suite 126
Belmont
California
94002
United States
Website: http://www.selonterra.com/
Email: admin@selonterra.com
About Selonterra
Selonterra was founded on the premise that a disruptive approach is required to address unmet medical needs in Alzheimer's disease (AD) and Parkinson's disease (PD).YEAR FOUNDED:
2008
LEADERSHIP:
Founder and CEO: Roman Urfer
Founder and CSO: Anne Urfer-Buchwalder
3 articles about Selonterra
-
Selonterra Awarded US$2,500,000 Grant from The Michael J. Fox Foundation for Parkinson's Research
3/8/2023
Selonterra, Inc., a biotechnology company developing transformative therapies for neurodegenerative disorders announces a grant award of US$2,500,000 from The Michael J. Fox Foundation for Parkinson's Research.
-
Selonterra Announces Presentation of Alzheimer’s Disease Therapy Program at Biotech Showcase™ 2020 in San Francisco
1/8/2020
Selonterra, Inc., a biotechnology company discovering transformative therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks announced a presentation at the Biotech Showcase™ 2020 to be held January 13–15 at the Hilton San Francisco Union Square.
-
Selonterra Release: Biotech Publishes Novel Proprietary Mechanism for APOE4 In Alzheimer’s Disease
1/17/2017